Result of AGM
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes
Roquefort Therapeutics (LSE:ROQ, OTCQB: ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth immuno-oncology market, is pleased to announce that at the Company's Annual General Meeting ("AGM") held earlier today, all resolutions proposed were duly passed.
The resolutions were put to shareholders via a poll, the results of which were as follows:
| Resolution | Poll Results | Total Votes Withheld* | |||
|---|---|---|---|---|---|
| For | Against | Total Votes Cast | |||
| 1 | Shares | 24,948,663 | - | 24,948,663 | - |
| % | 100.00% | - | |||
| 2 | Shares | 24,943,456 | - | 24,943,456 | 5,191 |
| % | 100.00% | - | |||
| 3 | Shares | 24,943,472 | - | 24,943,472 | 5,191 |
| % | 100.00% | - | |||
| 4 | Shares | 20,529,178 | - | 20,529,178 | 4,419,485 |
| % | 100.00% | - | |||
| 5 | Shares | 24,948,663 | - | 24,948,663 | - |
| % | 100.00% | - | |||
| 6 | Shares | 24,948,663 | - | 24,948,663 | - |
| % | 100.00% | - | |||
| 7 | Shares | 24,938,750 | 9,913 | 24,948,663 | - |
| % | 99.96% | 0.04% | |||
| 8 | Shares | 24,938,730 | 9,933 | 24,948,663 | - |
| % | 99.96% | 0.04% |
* Votes withheld are not counted in the calculation of the proportion of votes for and against a resolution.
The total number of ordinary shares in issue on 25 June 2024, the deadline for casting votes by proxy in advance of the AGM, was 129,149,998 shares. 19.3% of voting capital was instructed in respect of the resolutions put to the AGM.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.